查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1962086

全球藥物發現資訊學市場規模、佔有率、趨勢和成長分析報告（2026-2034）

Global Drug Discovery Informatics Market Size, Share, Trends & Growth Analysis Report 2026-2034
出版日期: | 出版商: Value Market Research | 英文 148 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

預計藥物發現資訊學市場將從 2025 年的 39.8 億美元成長到 2034 年的 87.1 億美元，2026 年至 2034 年的複合年成長率為 9.1%。

由於藥物研發過程日益複雜，以及對高效數據管理解決方案的需求不斷成長，藥物發現資訊學市場正經歷顯著成長。藥物發現資訊學涵蓋多種工具和技術，旨在促進藥物研發全生命週期中生物和化學數據的分析、視覺化和管理。隨著製藥公司加速研發，對能夠增強協作和數據整合的資訊學解決方案的需求預計將會增加，該市場預計將穩步擴張。

此外，資訊科技的進步正在推動藥物發現資訊學市場的創新。人工智慧 (AI)、機器學習 (ML) 和巨量資料分析的融合正在改變研究人員分析大量資料集的方式，從而能夠有效地識別潛在的候選藥物。這些技術促進了預測建模、虛擬篩檢和資料探勘，顯著降低了藥物發現所需的時間和成本。隨著藥物發現資訊學研究不斷深入新的調查方法和應用領域，在藥物研發效率和創新能力不斷提升的推動下，預計該市場將進一步擴張。

此外，研究機構和製藥公司之間合作研究和數據共用的重要性日益凸顯，正在塑造藥物發現資訊學的發展趨勢。隨著相關人員認知到合作研究的價值，對支援跨平台數據整合和共用的資訊學解決方案的需求預計將會上升。在開放科學計劃的背景下，這一趨勢尤其重要，因為數據透明度和可近性對於推進藥物發現至關重要。隨著藥物發現資訊學市場的不斷發展，技術進步、共同研究模式以及對數據驅動決策的重視，將在塑造其未來發展軌跡方面發揮關鍵作用。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

  • 市場譜系展望
  • 滲透率和成長前景分析
  • 價值鏈分析
  • 法律規範
    • 標準與合規性
    • 監管影響分析
  • 市場動態
    • 市場促進因素
    • 市場限制因素
    • 市場機遇
    • 市場挑戰
  • 波特五力分析
  • PESTLE分析

第4章：全球藥物發現資訊學市場：按應用領域分類

  • 市場分析、洞察與預測
  • 藥物發現
  • 藥物研發

第5章：全球藥物發現資訊學市場：依功能分類

  • 市場分析、洞察與預測
  • 定序和標靶數據分析
  • 圖書館和資料庫的準備工作
  • 對接，分子建模
  • 其他

第6章 全球藥物發現資訊學市場：依最終使用者分類

  • 市場分析、洞察與預測
  • 生技公司
  • 製藥公司
  • 受託研究機構
  • 其他

第7章 全球藥物發現資訊學市場：按地區分類

  • 區域分析
  • 北美市場分析、洞察與預測
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲市場分析、洞察與預測
    • 英國
    • 法國
    • 德國
    • 義大利
    • 俄羅斯
    • 其他歐洲國家
  • 亞太市場分析、洞察與預測
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 東南亞
    • 其他亞太國家
  • 拉丁美洲市場分析、洞察與預測
    • 巴西
    • 阿根廷
    • 秘魯
    • 智利
    • 其他拉丁美洲國家
  • 中東和非洲市場分析、洞察與預測
    • 沙烏地阿拉伯
    • UAE
    • 以色列
    • 南非
    • 其他中東和非洲國家

第8章 競爭情勢

  • 最新趨勢
  • 公司分類
  • 供應鏈和銷售管道合作夥伴（根據現有資訊）
  • 市場佔有率和市場定位分析（基於現有資訊）
  • 供應商情況（基於現有資訊）
  • 策略規劃

第9章：公司簡介

  • 主要公司的市佔率分析
  • 公司簡介
    • Certara
    • Boehringer Ingelheim International GmbH
    • Infosys Ltd
    • Charles River Laboratories
    • Collaborative Drug DiscoveryInc
    • Eurofins DiscoverX Products
    • Jubliant Biosys
    • Selvita
    • Novo Informatics Pvt. Ltd
    • ChemAxon Ltd
    • Albany Molecular Research Inc
    • Oracle
    • Accenture
    • Agilent TechnologiesInc
    • IlluminaInc
簡介目錄
Product Code: VMR112115285

The Drug Discovery Informatics Market size is expected to reach USD 8.71 Billion in 2034 from USD 3.98 Billion (2025) growing at a CAGR of 9.1% during 2026-2034.

The drug discovery informatics market is experiencing significant growth, driven by the increasing complexity of drug development processes and the need for efficient data management solutions. Drug discovery informatics encompasses a range of tools and technologies that facilitate the analysis, visualization, and management of biological and chemical data throughout the drug development lifecycle. As pharmaceutical companies seek to accelerate their research and development efforts, the demand for informatics solutions that enhance collaboration and data integration is expected to rise, positioning this market for robust expansion.

Moreover, advancements in informatics technologies are propelling innovation within the drug discovery informatics market. The integration of artificial intelligence (AI), machine learning (ML), and big data analytics is transforming the way researchers analyze vast datasets, enabling more efficient identification of potential drug candidates. These technologies facilitate predictive modeling, virtual screening, and data mining, significantly reducing the time and cost associated with drug discovery. As research continues to explore new methodologies and applications in drug discovery informatics, the market is likely to expand further, driven by the promise of enhanced efficiency and innovation in drug development.

Additionally, the growing emphasis on collaboration and data sharing among research institutions and pharmaceutical companies is shaping the drug discovery informatics landscape. As stakeholders recognize the value of collaborative research efforts, the demand for informatics solutions that support data integration and sharing across platforms is likely to increase. This trend is particularly relevant in the context of open science initiatives, where transparency and accessibility of data are essential for advancing drug discovery efforts. As the drug discovery informatics market continues to evolve, the combination of technological advancements, collaborative research models, and a focus on data-driven decision-making will play a crucial role in shaping its future trajectory.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Application

  • Drug Discovery
  • Drug Development

By Function

  • Sequencing and Target Data Analysis
  • Library and Database Preparation
  • Docking, Molecular Modelling
  • Others

By End User

  • Biotechnology Companies
  • Pharmaceutical Companies
  • Contract Research Organizations
  • Others

COMPANIES PROFILED

  • Certara, Boehringer Ingelheim International GmbH, Infosys Ltd, Charles River Laboratories, Collaborative Drug Discovery, Inc, Eurofins DiscoverX Products, Jubliant Biosys, Selvita, Novo Informatics Pvt Ltd, ChemAxon Ltd, Albany Molecular Research Inc, Oracle, Accenture, Agilent Technologies, Inc, Illumina, Inc

We can customise the report as per your requriements

TABLE OF CONTENTS

Chapter 1. PREFACE

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1 Information Analysis
    • 1.3.2 Market Formulation & Data Visualization
    • 1.3.3 Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

  • 2.1. Market Snapshot
  • 2.2. Segmental Outlook
  • 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

  • 3.1. Market Lineage Outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Value Chain Analysis
  • 3.4. Regulatory Framework
    • 3.4.1 Standards & Compliance
    • 3.4.2 Regulatory Impact Analysis
  • 3.5. Market Dynamics
    • 3.5.1 Market Drivers
    • 3.5.2 Market Restraints
    • 3.5.3 Market Opportunities
    • 3.5.4 Market Challenges
  • 3.6. Porter's Five Forces Analysis
  • 3.7. PESTLE Analysis

Chapter 4. GLOBAL DRUG DISCOVERY INFORMATICS MARKET: BY APPLICATION 2022-2034 (USD MN)

  • 4.1. Market Analysis, Insights and Forecast Application
  • 4.2. Drug Discovery Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.3. Drug Development Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL DRUG DISCOVERY INFORMATICS MARKET: BY FUNCTION 2022-2034 (USD MN)

  • 5.1. Market Analysis, Insights and Forecast Function
  • 5.2. Sequencing and Target Data Analysis Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.3. Library and Database Preparation Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.4. Docking, Molecular Modelling Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL DRUG DISCOVERY INFORMATICS MARKET: BY END USER 2022-2034 (USD MN)

  • 6.1. Market Analysis, Insights and Forecast End User
  • 6.2. Biotechnology Companies Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.3. Pharmaceutical Companies Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.4. Contract Research Organizations Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL DRUG DISCOVERY INFORMATICS MARKET: BY REGION 2022-2034(USD MN)

  • 7.1. Regional Outlook
  • 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.2.1 By Application
    • 7.2.2 By Function
    • 7.2.3 By End User
    • 7.2.4 United States
    • 7.2.5 Canada
    • 7.2.6 Mexico
  • 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.3.1 By Application
    • 7.3.2 By Function
    • 7.3.3 By End User
    • 7.3.4 United Kingdom
    • 7.3.5 France
    • 7.3.6 Germany
    • 7.3.7 Italy
    • 7.3.8 Russia
    • 7.3.9 Rest Of Europe
  • 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.4.1 By Application
    • 7.4.2 By Function
    • 7.4.3 By End User
    • 7.4.4 India
    • 7.4.5 Japan
    • 7.4.6 South Korea
    • 7.4.7 Australia
    • 7.4.8 South East Asia
    • 7.4.9 Rest Of Asia Pacific
  • 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.5.1 By Application
    • 7.5.2 By Function
    • 7.5.3 By End User
    • 7.5.4 Brazil
    • 7.5.5 Argentina
    • 7.5.6 Peru
    • 7.5.7 Chile
    • 7.5.8 South East Asia
    • 7.5.9 Rest of Latin America
  • 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.6.1 By Application
    • 7.6.2 By Function
    • 7.6.3 By End User
    • 7.6.4 Saudi Arabia
    • 7.6.5 UAE
    • 7.6.6 Israel
    • 7.6.7 South Africa
    • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

  • 8.1. Recent Developments
  • 8.2. Company Categorization
  • 8.3. Supply Chain & Channel Partners (based on availability)
  • 8.4. Market Share & Positioning Analysis (based on availability)
  • 8.5. Vendor Landscape (based on availability)
  • 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL DRUG DISCOVERY INFORMATICS INDUSTRY

  • 9.1. Top Companies Market Share Analysis
  • 9.2. Company Profiles
    • 9.2.1 Certara
    • 9.2.2 Boehringer Ingelheim International GmbH
    • 9.2.3 Infosys Ltd
    • 9.2.4 Charles River Laboratories
    • 9.2.5 Collaborative Drug DiscoveryInc
    • 9.2.6 Eurofins DiscoverX Products
    • 9.2.7 Jubliant Biosys
    • 9.2.8 Selvita
    • 9.2.9 Novo Informatics Pvt. Ltd
    • 9.2.10 ChemAxon Ltd
    • 9.2.11 Albany Molecular Research Inc
    • 9.2.12 Oracle
    • 9.2.13 Accenture
    • 9.2.14 Agilent TechnologiesInc
    • 9.2.15 IlluminaInc